DCF — ALEXIAN BROTHERS MEDICAL CENTER
Enterprise Value: $-398.4M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-398.4M
Enterprise Value
$-134.1M
PV of Cash Flows
$-264.3M
PV of Terminal Value
$-425.6M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $488.7M | $-20.4M | -4.0% | $-41.1M | $-37.4M |
| Year 2 | $503.4M | $-16.0M | -3.0% | $-37.3M | $-30.8M |
| Year 3 | $518.5M | $-11.3M | -2.0% | $-33.2M | $-25.0M |
| Year 4 | $534.1M | $-9.0M | -2.0% | $-31.6M | $-21.6M |
| Year 5 | $550.1M | $-7.9M | -1.0% | $-31.1M | $-19.3M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-398.4M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$474.5M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.04678470103175161
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5